BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates. 2012

Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Beijing Institute of Pharmacology and Toxicology, 27 Tai-Ping Road, Beijing 100850, China.

Twenty-one new 4-substituted diarylaniline compounds (DAANs) (series 13, 14, and 15) were designed, synthesized, and evaluated against wild-type and drug resistant HIV-1 viral strains. As a result, approximately a dozen new DAANs showed high potency with low nano- to subnanomolar EC(50) values ranging from 0.2 to 10 nM. The three most promising compounds 14e, 14h, and 15h exhibited high potency against wild-type and drug-resistant viral strains with EC(50) values at the subnanomolar level (0.29-0.87 nM) and were comparable to or more potent than the new NNRTI drug riplivirine (2) in the same assays. Druglike physicochemical property assessments revealed that the most active DAANs (EC(50) < 10 nM) have better aqueous solubility (>1-90 μg/mL at pH 7.4 and pH 2) and metabolic stability in vitro than 2, as well as desirable log P values (<5) and polar surface areas (PSA) (<140 Å(2)). These promising results warrant further development of this novel compound class as potential potent anti-AIDS clinical trial candidates.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
December 2010, Journal of medicinal chemistry,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus.
June 2017, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2012, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
February 2019, ACS medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I.
April 2006, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2.
April 2006, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
February 2014, Bioorganic & medicinal chemistry,
Lian-Qi Sun, and Lei Zhu, and Keduo Qian, and Bingjie Qin, and Li Huang, and Chin Ho Chen, and Kuo-Hsiung Lee, and Lan Xie
Rational design and synthesis of novel thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors.
June 2014, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!